Daniel Garlitos, MD
NPI 1386629574 · Radiation Oncology Physician · Lake Jackson, TX
Enrolled with Medicare as Practitioner - Radiation Oncology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1386629574
- Entity type
- Individual
- Primary specialty
- Radiation Oncology PhysicianAllopathic & Osteopathic Physicians
- Credential
- MD
- Sex
- Male
- Sole proprietor
- Yes
- License
- K7742 (TX)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
20 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
2,212 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Intensity Modulated Treatment Delivery, Single Or Multiple Fields/Arcs,via Narrow Spatially and Temporally Modulated Beams, Binary, Dynamic Mlc, Per Treatment SessionG6015 | 617 | $338 |
| Ct Guidance for Insertion of Radiation Therapy Fields77014 | 592 | $117 |
| Ct Guidance for Insertion of Radiation Therapy Fields77014 | 371 | $44 |
| Continuing Radiation Therapy Consultation Per Week77336 | 129 | $88 |
| Radiation Treatment Management, 5 Treatment Sessions77427 | 109 | $186 |
| Radiation Treatment Management, 5 Treatment Sessions77427 | 105 | $190 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 7 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Tamsulosin Hcl | 72 | 21 |
| Relugolixbrand: Orgovyx | 68 | — |
| Levothyroxine Sodium | 57 | 11 |
| Anastrozole | 21 | — |
| Hydrocortisone | 14 | — |
| Alfuzosin Hclbrand: Alfuzosin Hcl Er | 13 | — |
| Hydrocodone/Acetaminophenbrand: Hydrocodone-Acetaminophen |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$80 across 3 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2005-12-09
- Last updated
- 2025-01-23
- Certified
- 2025-01-23
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.